- Business
- Camlin Fine Sciences Limited Camlin Fine Sciences Limited manufactures specialty chemicals focused on shelf-life extension solutions, aroma ingredients, and performance chemicals for industries including food and beverages, animal nutrition, pet food, petrochemicals, pharmaceuticals, agrochemicals, and polymers. The company produces antioxidants such as tert-Butylhydroquinone (TBHQ) and Butylated hydroxyanisole (BHA), where it holds global leadership; natural alternatives under brands like Xtendra, NaSure, and Ezential for food protection in snacks, bakery, meat, poultry, and biodiesel; aroma compounds including vanillin and ethyl vanillin under adorr, Vanesse, and Evanil for flavors, fragrances, incense, and pharmaceuticals; performance chemicals such as hydroquinone, catechol, and derivatives under Dinamic for petrochemicals, dyes, pigments, and polymers; and innovative products like Biosus vegan DHA from algae and floral boosters for enhanced aroma in consumer goods. Founded in 1993 and headquartered in Mumbai, India, Camlin Fine Sciences Limited operates manufacturing facilities and offices across India, Italy, Belgium, France, Mexico, Brazil, the United States, Singapore, and other regions in Asia, Europe, the Americas, and the Middle East & Africa, serving a global sales network in over 160 locations with more than 1,000 employees and annual turnover exceeding USD 200 million. Recent strategic expansions include the 2024 acquisition of Vitafor Invest NV in Belgium by its Mexican subsidiary Dresen Quimica to bolster animal nutrition capabilities; an $11 million offshore funding in late 2024 to secure full ownership of Dresen Quimica from its joint venture partner; and the November 2025 completion of a majority 78.68% stake acquisition in French firm Vinpai S.A. via share swaps, convertible bonds worth €3.3 million, and tender offers, enhancing natural functional ingredients from algae, plants, and fibers to tap sustainable clean-label trends in specialty chemicals.